ITGAM and relapsing-remitting multiple sclerosis: These data could be reproduced in mice, since at onset of disease CD11b+ splenocytes showed almost normal NOX activation (5.0 ± 1.1 % %), while at peak of disease the values were similar to those measured in untreated RRMS patients (18.5 ± 3.5 %).